<DOC>
	<DOCNO>NCT02137369</DOCNO>
	<brief_summary>While many effective option treat major depressive episode , clinical marker predict likelihood remission initial trial either antidepressant medication psychotherapy . The goal study test brain function change depress patient treat cognitive behavioral therapy ( CBT ) compare patient treat escitalopram ( ( s-CIT ) - Lexapro® ) , FDA approve antidepressant . The study aim determine bran scan finding might help physician select effective antidepressant treatment individual patient . At total 150 male female outpatient 21-55 year old enrol . Participation study last 14-26 week . Subjects randomize receive either escitalopram ( s-CIT ) CBT 12 week . Resting-state positron emission tomography ( PET ) BOLD functional magnetic resonance imaging ( fMRI ) scan do treatment begin , end treatment ( week 12 ) . Non-responders s-cIT CBT cross receive additional 12 week treatment alternative intervention .</brief_summary>
	<brief_title>The ISLAND Study : InSuLa Assessed Needs Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>1 . Men woman age 1860 year . 2 . Primary psychiatric diagnosis Major Depressive Disorder , without psychotic feature , confirm via SCIDIV structure diagnostic interview . 3 . Screening Hamilton Depression Rating Scale ( HAMD ) ≥ 18 ; Baseline HAMD ≥ 15 . 4 . If patient woman childbearing potential , must agree use acceptable form birth control duration study participation . 5 . Able understand provide inform consent participation . 1 . Lifetime history Bipolar Disorder , Dementia , Autism Spectrum Disorder , Schizophrenia , Psychotic Disorder . 2 . Psychotic symptom occur time current major depressive episode . 3 . Current ( past 12 month ) diagnosis Panic disorder , Obsessive Compulsive Disorder , Posttraumatic Stress Disorder , Anorexia Nervosa , Bulimia Nervosa . 4 . Alcohol Drug Dependence within 12 month Abuse within 3 month ( exclude nicotine caffeine ) baseline visit , assess history urine drug screen . 5 . Clinical evidence severe Personality Disorder , assess study psychiatrist , would impede participation completion trial . 6 . Known neurological disorder document serious head injury . 7 . Serious unstable medical illness include cardiovascular disease cancer . 8 . Active medical condition know mood change ( endocrine , autoimmune disorder ) . 9 . Current diabetes mellitus . 10 . For woman , pregnancy , lactation , unwillingness comply birth control requirement . 11 . Use follow treatment alternative therapy within 2 week pretreatment PET scan may beneficial effect mood , include St John 's Wort , Sadenosyl methionine ( SAMe ) , n3 fatty acid , light therapy . 12 . Use antidepressant medication within 1 month pretreatment PET scan ( within 5 week fluoxetine protryptyline ) . 13 . Failure achieve much improve status ( i.e . equivalent &gt; 50 % symptom reduction ) lifetime treatment course CBT ( define minimum 4 session specify manualdriven therapy CBTtrained therapist ) escitalopram ( define minimum 6 week least 10 mg/day ) . 14 . Clinically significant active suicidal ideation selfinjurious behavior necessitate immediate treatment , determine investigator . 15 . Received electroconvulsive therapy past 6 month current depressive episode . 16 . Currently respond medication treatment , without clinical reason change . 17 . Current treatment weekly individual group psychotherapy type target depressive symptom . 18 . QTc &gt; 500 millisecond EKG screening . 19 . Contraindications MRI , include , limited pacemaker , aneurysm clip , neurostimulators , cochlear implant , metal eye , steel worker , intrauterine device birth control . 20 . Use concomitant medication exception : Maintenance prophylactic therapy stable medical condition . Hypnotic medication prescribe approve study physician , ( three dos per week ) insomnia , long night PET/MRI clinic rating visit . Antipsychotic medication , whether prescribed sleep indication , prohibit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>MDD</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Treatment</keyword>
	<keyword>Antidepressants</keyword>
	<keyword>Lexapro</keyword>
	<keyword>Talk therapy</keyword>
</DOC>